{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:43:53Z","timestamp":1761612233651,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.pdpdt.2021.102390","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T02:14:07Z","timestamp":1623377647000},"page":"102390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The role of oral steroids in the treatment of photodynamic therapy-associated exudative maculopathy, a case report and review of the literature"],"prefix":"10.1016","volume":"35","author":[{"given":"Andrew J.","family":"Sumnicht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kakarla V.","family":"Chalam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel E.","family":"Alset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I.","family":"Sierpina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pdpdt.2021.102390_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV)","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102390_bib0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","article-title":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients","volume":"144","author":"Maruko","year":"2007","journal-title":"Am. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.pdpdt.2021.102390_bib0003","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s004170000180","article-title":"Polypoidal choroidal vasculopathy in Caucasians","volume":"238","author":"Lafaut","year":"2000","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.pdpdt.2021.102390_bib0004","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","article-title":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy","volume":"15","author":"Spaide","year":"1995","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102390_bib0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/IAE.0b013e3181884fbf","article-title":"Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography","volume":"29","author":"Ojima","year":"2009","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.pdpdt.2021.102390_bib0006","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","article-title":"Pachychoroid pigment epitheliopathy","volume":"33","author":"Warrow","year":"2013","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.pdpdt.2021.102390_bib0007","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy","volume":"32","author":"Koh","year":"2012","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.pdpdt.2021.102390_bib0008","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial","volume":"135","author":"Koh","year":"2017","journal-title":"JAMA Ophthalmol."},{"issue":"4","key":"10.1016\/j.pdpdt.2021.102390_bib0009","first-page":"359","article-title":"Polypoidal choroidal vasculopathy: an update on therapeutic approaches","volume":"8","author":"Wong","year":"2013","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.pdpdt.2021.102390_bib0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.preteyeres.2013.09.003","article-title":"Photodynamic therapy for polypoidal choroidal vasculopathy","volume":"37","author":"Nowak-Sliwinska","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102390_bib0011","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/j.jcjo.2016.08.001","article-title":"Atypical transient subretinal exudation following photodynamic therapy for chronic central serous retinopathy: a case report","volume":"52","author":"Al-Awadi","year":"2017","journal-title":"Can. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.pdpdt.2021.102390_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-231865","article-title":"Photodynamic therapy-induced acute exudative maculopathy in a case of choroidal haemangioma","volume":"12","author":"Chakurkar","year":"2019","journal-title":"BMJ Case Rep."},{"issue":"6","key":"10.1016\/j.pdpdt.2021.102390_bib0013","first-page":"CS75","article-title":"Severe decrease in visual acuity with choroidal hypoperfusion after photodynamic therapy","volume":"17","author":"Figurska","year":"2011","journal-title":"Med. Sci. Monit."},{"issue":"3","key":"10.1016\/j.pdpdt.2021.102390_bib0014","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/ICB.0000000000000356","article-title":"Incidence of Acute Exudative Maculopathy after Reduced-Fluence Photodynamic Therapy","volume":"11","author":"Mammo","year":"2017","journal-title":"Retin. Cases Brief Rep."},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102390_bib0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/IAE.0000000000002343","article-title":"PHOTODYNAMIC THERAPY-INDUCED ACUTE EXUDATIVE MACULOPATHY: Incidence, Clinical Features, and Long-Term Outcomes","volume":"40","author":"Manayath","year":"2020","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.pdpdt.2021.102390_bib0016","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3341\/kjo.2015.29.2.143","article-title":"Massive exudative retinal detachment following photodynamic therapy and intravitreal bevacizumab injection in retinal capillary hemangioma","volume":"29","author":"Kim","year":"2015","journal-title":"Korean J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.pdpdt.2021.102390_bib0017","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.vph.2006.09.006","article-title":"Combination therapy using aspirin-enhanced photodynamic selective drug delivery","volume":"46","author":"Debefve","year":"2007","journal-title":"Vascul. Pharmacol."},{"issue":"6","key":"10.1016\/j.pdpdt.2021.102390_bib0018","first-page":"835","article-title":"Histopathological changes following photodynamic therapy in human eyes","volume":"120","author":"Schmidt-Erfurth","year":"2002","journal-title":"Arch. Ophthalmol."},{"issue":"18","key":"10.1016\/j.pdpdt.2021.102390_bib0019","first-page":"4914","article-title":"The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion","volume":"52","author":"Fingar","year":"1992","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.pdpdt.2021.102390_bib0020","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1167\/iovs.02-1115","article-title":"Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor","volume":"44","author":"Schmidt-Erfurth","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.pdpdt.2021.102390_bib0021","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archopht.1996.01100140186012","article-title":"Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization","volume":"114","author":"Husain","year":"1996","journal-title":"Arch. Ophthalmol."},{"issue":"6","key":"10.1016\/j.pdpdt.2021.102390_bib0022","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/IAE.0b013e318042d3b0","article-title":"Influence of verteporfin photodynamic therapy on inflammation in human choroidal neovascular membranes secondary to age-related macular degeneration","volume":"27","author":"Tatar","year":"2007","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102390_bib0023","first-page":"63","article-title":"Anti-VEGF Agents and the Risk of Arteriothrombotic Events","volume":"7","author":"Zarbin","year":"2018","journal-title":"Asia Pac. J. Ophthalmol. (Phila)"},{"issue":"4","key":"10.1016\/j.pdpdt.2021.102390_bib0024","doi-asserted-by":"crossref","first-page":"738-744 e1","DOI":"10.1016\/j.ajo.2014.06.009","article-title":"Serum and plasma vascular endothelial growth factor concentrations before and after intravitreal injection of aflibercept or ranibizumab for age-related macular degeneration","volume":"158","author":"Wang","year":"2014","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.pdpdt.2021.102390_bib0025","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/bjophthalmol-2012-302451","article-title":"Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema","volume":"97","author":"Zehetner","year":"2013","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.pdpdt.2021.102390_bib0026","first-page":"408","article-title":"Choroidal thickening and pachychoroid in cushing syndrome","volume":"39","author":"Wang","year":"2019","journal-title":"Correlation Endogenous Cortisol Level. Retina."},{"issue":"2","key":"10.1016\/j.pdpdt.2021.102390_bib0027","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00006982-199616020-00003","article-title":"Idiopathic polypoidal choroidal vasculopathy associated with retinal arterial macroaneurysm and hypertensive retinopathy","volume":"16","author":"Ross","year":"1996","journal-title":"Retina"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021002179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021002179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:39:50Z","timestamp":1761611990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100021002179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":27,"alternative-id":["S1572100021002179"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102390","relation":{},"ISSN":["1572-1000"],"issn-type":[{"type":"print","value":"1572-1000"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of oral steroids in the treatment of photodynamic therapy-associated exudative maculopathy, a case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102390"}}